These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 31682804)

  • 21. Sulfocoumarins, specific carbonic anhydrase IX and XII inhibitors, interact with cancer multidrug resistant phenotype through pH regulation and reverse P-glycoprotein mediated resistance.
    Podolski-Renić A; Dinić J; Stanković T; Jovanović M; Ramović A; Pustenko A; Žalubovskis R; Pešić M
    Eur J Pharm Sci; 2019 Oct; 138():105012. PubMed ID: 31330259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Promising Microtubule Inhibitor Deoxypodophyllotoxin Exhibits Better Efficacy to Multidrug-Resistant Breast Cancer than Paclitaxel via Avoiding Efflux Transport.
    Zang X; Wang G; Cai Q; Zheng X; Zhang J; Chen Q; Wu B; Zhu X; Hao H; Zhou F
    Drug Metab Dispos; 2018 May; 46(5):542-551. PubMed ID: 29523600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MAY, a novel tubulin inhibitor, induces cell apoptosis in A549 and A549/Taxol cells and inhibits epithelial-mesenchymal transition in A549/Taxol cells.
    Du J; Li J; Gao M; Guan Q; Liu T; Wu Y; Li Z; Zuo D; Zhang W; Wu Y
    Chem Biol Interact; 2020 May; 323():109074. PubMed ID: 32217108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MHY451 induces cell cycle arrest and apoptosis by ROS generation in HCT116 human colorectal cancer cells.
    Hwang NL; Kang YJ; Sung B; Hwang SY; Jang JY; Oh HJ; Ahn YR; Kim DH; Kim SJ; Ullah S; Hossain MA; Moon HR; Chung HY; Kim ND
    Oncol Rep; 2017 Sep; 38(3):1783-1789. PubMed ID: 28731136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solasodine targets NF-κB signaling to overcome P-glycoprotein mediated multidrug resistance in cancer.
    Bharathiraja P; Balamurugan K; Govindasamy C; Prasad NR; Pore PM
    Exp Cell Res; 2024 Aug; 441(1):114153. PubMed ID: 39013486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A newly synthesized nickel chelate can selectively target and overcome multidrug resistance in cancer through redox imbalance both in vivo and in vitro.
    Banerjee K; Biswas MK; Choudhuri SK
    J Biol Inorg Chem; 2017 Dec; 22(8):1223-1249. PubMed ID: 29063196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P-glycoprotein-evading anti-tumor activity of a novel tubulin and HSP90 dual inhibitor in a non-small-cell lung cancer model.
    Zhang Q; Zhai S; Li L; Li X; Jiang C; Zhang C; Yan B
    J Pharmacol Sci; 2014; 126(1):66-76. PubMed ID: 25185500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Taxol Analogues Exhibit Differential Effects on Photoaffinity Labeling of β-Tubulin and the Multidrug Resistance Associated P-Glycoprotein.
    Yang CH; Wang C; Ojima I; Horwitz SB
    J Nat Prod; 2018 Mar; 81(3):600-606. PubMed ID: 29517223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in alpha-tubulin.
    Loganzo F; Hari M; Annable T; Tan X; Morilla DB; Musto S; Zask A; Kaplan J; Minnick AA; May MK; Ayral-Kaloustian S; Poruchynsky MS; Fojo T; Greenberger LM
    Mol Cancer Ther; 2004 Oct; 3(10):1319-27. PubMed ID: 15486199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orally bioavailable tubulin antagonists for paclitaxel-refractory cancer.
    Li CM; Lu Y; Chen J; Costello TA; Narayanan R; Dalton MN; Snyder LM; Ahn S; Li W; Miller DD; Dalton JT
    Pharm Res; 2012 Nov; 29(11):3053-63. PubMed ID: 22760659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and antineoplastic activity of novel hybrids of podophyllotoxin and indirubin against human leukaemia cancer cells as multifunctional anti-MDR agents.
    Wang J; Long L; Chen Y; Xu Y; Zhang L
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1817-1824. PubMed ID: 29678463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel tubulin polymerization inhibitors overcome multidrug resistance and reduce melanoma lung metastasis.
    Wang Z; Chen J; Wang J; Ahn S; Li CM; Lu Y; Loveless VS; Dalton JT; Miller DD; Li W
    Pharm Res; 2012 Nov; 29(11):3040-52. PubMed ID: 22410804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells.
    Yan J; Pang Y; Sheng J; Wang Y; Chen J; Hu J; Huang L; Li X
    Biochem Pharmacol; 2015 Sep; 97(1):51-61. PubMed ID: 26212540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Spleen Tyrosine Kinase Inhibitor, Entospletinib (GS-9973) Restores Chemosensitivity in Lung Cancer Cells by Modulating ABCG2-mediated Multidrug Resistance.
    Narayanan S; Wu ZX; Wang JQ; Ma H; Acharekar N; Koya J; Yoganathan S; Fang S; Chen ZS; Pan Y
    Int J Biol Sci; 2021; 17(10):2652-2665. PubMed ID: 34326700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel curcumin derivative which inhibits P-glycoprotein, arrests cell cycle and induces apoptosis in multidrug resistance cells.
    Lopes-Rodrigues V; Oliveira A; Correia-da-Silva M; Pinto M; Lima RT; Sousa E; Vasconcelos MH
    Bioorg Med Chem; 2017 Jan; 25(2):581-596. PubMed ID: 27908756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agents.
    Goard CA; Mather RG; Vinepal B; Clendening JW; Martirosyan A; Boutros PC; Sharom FJ; Penn LZ
    Int J Cancer; 2010 Dec; 127(12):2936-48. PubMed ID: 21351272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, In silico and In vitro Studies Providing Mechanistic Insight into Their Anticancer Potencies.
    Sever B; Altıntop MD; Çiftçi GA; Özdemir A
    Med Chem; 2021; 17(10):1104-1128. PubMed ID: 33087032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glaucarubinone sensitizes KB cells to paclitaxel by inhibiting ABC transporters via ROS-dependent and p53-mediated activation of apoptotic signaling pathways.
    Karthikeyan S; Hoti SL; Nazeer Y; Hegde HV
    Oncotarget; 2016 Jul; 7(27):42353-42373. PubMed ID: 27304668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-Phenyl-5-(pyrrolidin-1-yl)-1-(3,4,5-trimethoxybenzyl)-1H-benzimidazole, a benzimidazole derivative, inhibits growth of human prostate cancer cells by affecting tubulin and c-Jun N-terminal kinase.
    Chang WL; Chang CS; Chiang PC; Ho YF; Liu JF; Chang KW; Guh JH
    Br J Pharmacol; 2010 Aug; 160(7):1677-89. PubMed ID: 20649571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter.
    Zhang Q; Song Y; Cheng X; Xu Z; Matthew OA; Wang J; Sun Z; Zhang X
    Anticancer Res; 2019 Oct; 39(10):5461-5471. PubMed ID: 31570440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.